Thymosin alpha-1 (28-amino-acid peptide)
A naturally occurring 28-amino-acid peptide studied within immunomodulation and immune-signaling research.
Thymosin α-1 is a 28-amino-acid peptide originally isolated from thymic tissue. It is well characterized in the scientific literature and studied in the context of immune signaling.
Research on Thymosin α-1 spans preclinical and clinical literature in various regions. NorthPeak presents it here as an informational research entry and makes no treatment claims.
Yes. It was originally identified in thymic tissue and is a naturally occurring peptide.
Research disclaimer. All information on NorthPeak Peptides is provided for educational and informational purposes only. It is not medical advice and is not intended to diagnose, treat, cure, or prevent any disease. Materials referenced are described for research context and are not offered for human consumption. Always consult a qualified, licensed healthcare professional regarding your health.
Lysine–Proline–Valine tripeptide
A tripeptide corresponding to the C-terminal sequence of α-MSH, studied within anti-inflammatory signaling research.
View Research ProfileTriple incretin receptor agonist (investigational)
An investigational synthetic peptide studied as a triple agonist of the GIP, GLP-1, and glucagon receptors in metabolic research.
View Research ProfileSynthetic peptide related to Thymosin β-4
A synthetic peptide associated with the actin-binding region of Thymosin β-4, studied in cell-migration and tissue-repair research models.
View Research Profile